Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, Y.
Right arrow Articles by Sugimachi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, Y.
Right arrow Articles by Sugimachi, K.

Annals of Surgical Oncology, Vol 4, Issue 2 137-140, Copyright © 1997 by Society of Surgical Oncology

ARTICLES

Tumor size as a simple prognostic indicator for gastric carcinoma

Y. Adachi, T. Oshiro, M. Mori, Y. Maehara and K. Sugimachi
Second Department of Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

BACKGROUND: Tumor size can be measured easily before or during operation with no special tools, but its prognostic use in patients with gastric carcinoma is still unclear. METHODS: Clinicopathologic data of 479 patients who underwent curative operation for gastric carcinoma were studies. The relationship between tumor size and survival of patients was investigated. RESULTS: The patients were divided into three groups: 182 with tumors measuring < 4 cm (group I), 252 with tumors of 4-10 cm (group II), and 45 with tumors of > or = 10 cm (group III). The 10-year survival rates for group I, II, and III patients were 92%, 66% and 33%, respectively (p < 0.01), and the three groups were significantly different with regard to depth of invasion (p < 0.01), number and level of lymph node metastasis (p < 0.01), and stage of disease (p < 0.01). Multivariate analysis indicated that tumor size independently influenced the survival of patients. CONCLUSIONS: Tumor size clinically serves as a simple predictor of tumor progression and survival of patients in gastric carcinoma.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
C. Kunisaki, H. Makino, R. Takagawa, T. Oshima, Y. Nagano, T. Kosaka, H. A. Ono, Y. Otsuka, H. Akiyama, Y. Ichikawa, et al.
Tumor Diameter as a Prognostic Factor in Patients with Gastric Cancer
Ann. Surg. Oncol., July 1, 2008; 15(7): 1959 - 1967.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S A Pritchard
Best practice in macroscopic examination of gastric resections
J. Clin. Pathol., February 1, 2008; 61(2): 172 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. Yasuda, M. Inomata, K. Fujii, N. Shiraishi, Y. Adachi, and S. Kitano
Superficially Spreading Cancer of the Stomach
Ann. Surg. Oncol., March 1, 2002; 9(2): 192 - 196.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A O O Chan, S K Lam, K M Chu, C M Lam, E Kwok, S Y Leung, S T Yuen, S Y K Law, W M Hui, K C Lai, et al.
Soluble E-cadherin is a valid prognostic marker in gastric carcinoma
Gut, June 1, 2001; 48(6): 808 - 811.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Society of Surgical Oncology.